Ahn-Robbins D, Grootendorst-van Mil NH, Chang CK, Chandran D, Shetty H, Sanyal J, MacCabe JH, Cohen H, Stewart R, Schirmbeck F, de Haan L, Hayes RD. Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder. J Clin Psychiatry. 2022 83(6)
Berendsen S, Nummenin E, Schirmbeck F, de Haan L, van Tricht MJ, GROUP Investigators . Association of cognitive performance with clinical staging in schizophrenia spectrum disorders: a prospective 6-year follow-up study. Schizophr Res Cogn. 2022 28:100232.
Burin LM, Hahn MK, da Rocha NS, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, de Haan L, Schirmbeck F, Simons CJP, van Os J, Cahn W. Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study. Psychiatry Res. 2022 314:114680.
Czepiel D, Hoek HW, van der Markt A, Rutten BPF, Veling W, Schirmbeck F, Mascayano F, Susser ES, van der Ven E. The Association Between Exposure to COVID-19 and Mental Health Outcomes Among Healthcare Workers. Front Public Health. 2022 10:896843.
Isvoranu AM, Ziermans T, Schirmbeck F, Borsboom D, Geurts HM, de Haan L, GROUP Investigators . Autistic Symptoms and Social Functioning in Psychosis: A Network Approach. Schizophr Bull. 2022 48(1):273-282.
Jaya ES, Wüsten C, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NE, van Os J, van Winkel R, Fonseca-Pedrero E, Peters E, Verdoux H, Woodward TS, Ziermans TB, Lincoln T.M.. Comparing psychotic experiences in low-and-middle-income-countries and high-income-countries with a focus on measurement invariance. Psychol Med. 2022 52(8):1509-1516.
Moura BM, Isvoranu AM, Kovacs V, Van Rooijen G, van Amelsvoort T, Simons CJP, Bartels-Velthuis AA, Bakker PR, Marcelis M, de Haan L, Schirmbeck F. The Puzzle of Functional Recovery in Schizophrenia-Spectrum Disorders-Replicating a Network Analysis Study. Schizophr Bull. 2022 48(4):871-880.
Moura BM, Van Rooijen G, Schirmbeck F, Wigman JTW, Genetic Risk and Outcome of Psychosis (GROUP) investigators
, Madeira L, van Harten P, van Os J, Bakker PR, Marcelis M. Corrigendum to: A Network of Psychopathological, Cognitive, and Motor Symptoms in Schizophrenia Spectrum Disorders. Schizophr Bull. 2022 48(3):721-722.
Myin-Germeys I, van Aubel E, Vaessen T, Steinhart H, Klippel A, Lafit G, Viechtbauer W, Batink T, van Winkel R, van der Gaag M, van Amelsvoort T, Marcelis M, Schirmbeck F, de Haan L, Reininghaus U. Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial. Psychother Psychosom. 2022 91(6):411-423. Epub 2022 Mar 18.
Schirmbeck F, Zink M. [Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment]. Nervenarzt. 2022 93(7):688-694.
Schirmbeck F, van der Ven E, Boyette LL, McGuire P, Valmaggia LR, Kempton MJ, van der Gaag M, Riecher-Rössler A, Barrantes-Vidal N, Nelson B, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, Nordentoft M, EU-GEI High Risk Study Group , de Haan L, Vermeulen JM. Differential trajectories of tobacco smoking in people at ultra-high risk for psychosis: Associations with clinical outcomes. Front Psychiatry. 2022 13:869023.
van der Heijden HS, Schirmbeck F, Berry L, Simons CJP, Bartels-Velthuis AA, Bruggeman R, de Haan L, Vermeulen J. Impact of coping styles on substance use in persons with psychosis, siblings, and controls. Schizophr Res. 2022 241:102-109.
van der Heijden HS, Schirmbeck F, Kempton MJ, van der Gaag M, Allott K, Nelson B, Ruhrmann S, de Haan L, Vermeulen JM, Eu-Gei High Risk Study . Impact of smoking behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study - CORRIGENDUM. Eur Psychiatry. 2022 65(1):e17.